-

08:55:03 PM

TSOI Stock News

TSOI - Therapeutic Solutions International Inc

09/22/21 9:00 AM

OTC : TSOI

covid-19

Therapeutic Solutions International Discovers and Files Patent on Novel Cellular Therapy Combination for Augmentation of Lung Repair in COVID-19 Model

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a patent demonstrating synergistic suppression of lung injury and acceleration of lung regeneration by combining T regulatory cells and

RHEA-AI

neutral

09/16/21 9:00 AM

OTC : TSOI

covid-19

Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMune™ and Ivermectin in Animal Models of COVID-19 Pathology

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating positive effects when its commercially available nutraceutical, QuadraMune™, is administered together with ivermectin in animals suffering from

RHEA-AI

neutral

09/13/21 9:00 AM

OTC : TSOI

Therapeutic Solutions International Successfully Treats Veteran Navy SEAL Suffering from Chronic Traumatic Encephalopathy with JadiCell™ Adult Stem Cells Under Right to Try Law

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today successful treatment of a United States Navy SEAL Veteran suffering from Chronic Traumatic Encephalopathy (CTE). The patient received 2 injections of the JadiCell adult

RHEA-AI

negative

09/10/21 9:00 AM

OTC : TSOI

clinical trialcovid-19

Therapeutic Solutions International Engages Venvalo Group to Oversee JadiCell COVID-19 Phase III Clinical Trial and Emergency Use Authorization (EUA) Process

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today the engagement of Venvalo Group to assist the Company on regulatory, strategic, and implementation aspects of the recently FDA-cleared Phase III clinical trial assessing

RHEA-AI

very positive

09/07/21 9:00 AM

OTC : TSOI

Therapeutic Solutions International Signs Memorandum of Understanding with Clinical Stage Immunotherapy Company Eutilogics, Inc. to Explore Augmentation of Synergies between StemVacs-V and TAST

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today the signing of a memorandum of understanding with immunotherapy company Eutilogics, Inc., the wholly owned subsidiary of clinical stage Korean company, Eutilex Co., Ltd.,

RHEA-AI

neutral

08/26/21 9:00 AM

OTC : TSOI

management

Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Pioneer Francisco Silva to Scientific Advisory Board

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today the recruitment of stem cell pioneer and key opinion leader Francisco Silva to the Company's Scientific Advisory Board. Mr. Silva will join other Key Opinion Leaders such as

RHEA-AI

very positive

08/23/21 9:00 AM

OTC : TSOI

clinical trial

Therapeutic Solutions International Announces Positive Preclinical Results Using JadiCells™ in Animal Model of Chronic Obstructive Pulmonary Failure (COPD)

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced new data and a patent filing covering the use of JadiCells™ and various therapeutic combinations for the treatment of COPD. The experiments involved administration of JadiCells™

RHEA-AI

neutral

08/20/21 9:00 AM

OTC : TSOI

management

Therapeutic Solutions International Announces Titan of Industry Dr. Peter Farrell Joins Advisory Board of its Suicide Prevention Spin-Off Campbell Neurosciences

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today that Peter C Farrell, PhD, DSc, AM joined the Advisory Board of its Spin-Off Company Campbell Neurosciences.Campbell Neurosciences is focused on approaching suicide as a

RHEA-AI

positive

08/19/21 9:00 AM

OTC : TSOI

clinical trialcovid-19

Therapeutic Solutions International Recruits Pharmaceutical Industry Veteran Dr. Boris Reznik to Accelerate Value Optimization of FDA Cleared Phase III COVID JadiCell™ Clinical Trial

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today recruitment of Dr. Boris Reznik to the Company's Advisory Board.Boris Reznik is the Chairman of Venvalo Group, a venture value optimization firm. During his career, Dr.

RHEA-AI

very positive

08/18/21 9:00 AM

OTC : TSOI

covid-19

Therapeutic Solutions International Identifies and Files Patent on Novel Mechanism of Action of Its FDA Phase III Cleared JadiCell™ Treatment of COVID-19 and Delta Variant

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a patent application describing a unique mechanism of action of its JadiCell™ universal donor stem cell. The Company used an animal model of

RHEA-AI

neutral

1 2 3 4 5 6 Next